Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
21JUL

Ebola case fatality crosses 40% in DRC

2 min read
09:12UTC

Africa CDC put Bundibugyo case fatality at 44.1% on 27 July, up from about 39.7% a week earlier, and attributes the rise to later presentation and saturated treatment sites.

ScienceDeveloping
Key takeaway

Bundibugyo now kills 44.1% of confirmed cases, driven by late presentation rather than the virus.

Case fatality among confirmed Bundibugyo Ebola cases in DR Congo reached 44.1% on 27 July, up from roughly 39.7% a week earlier, Africa CDC reported 1. The agency attributes the rise to patients arriving later and to treatment sites running full, not to any change in the pathogen. Its headline totals now stand at 3,380 confirmed cases and 1,489 deaths, against 2,344 and 930 seven days before .

Those totals need one caveat carried alongside them. Africa CDC's own chart note marks the 22 July step change as retrospective harmonisation with the Ituri and North Kivu case registers rather than a single-day surge 2. Read off the chart gridlines, the back-filled portion runs somewhere near 350 to 400 cases, an estimate rather than a figure the agency states. A meaningful share of the apparent week is therefore old cases arriving late in the ledger, and the raw difference between the two totals overstates how fast the epidemic moved.

Readers reaching for the 2018-20 Kivu epidemic as a yardstick will reach wrong. Kivu killed about 66% of those it infected, but Kivu was Zaire ebolavirus, a different species from the Bundibugyo ebolavirus circulating now. Bundibugyo has two earlier outbreaks in the literature: Uganda in 2007, with 131 cases and 39 deaths, and Isiro in eastern DRC in 2012, with 38 cases and 13 deaths, close to 30% in the first and 34% in the second. Measured against Kivu, 44.1% looks merciful. Measured against its own species, it runs ten points above anything Bundibugyo has done before, and the drift from 39.7% in seven days is the part that should concern anyone reading the trend rather than the level. Isolation coverage was already near 44% when WHO put cases at 1,481 in early July ; untreated Ebola kills at rates no species comparison can soften.

Deep Analysis

In plain English

Case-fatality rate means the share of confirmed patients who die from the disease. It has climbed from about 40% to 44% in a week. Africa CDC says this is not because the virus has become more dangerous, but because sick people are reaching treatment later and the treatment sites they do reach are overloaded. Getting care quickly matters enormously with Ebola, so anything that delays it, whether that is distance, an overwhelmed hospital, or a shortage of isolation beds, translates directly into more deaths among the people who do get diagnosed.

Deep Analysis
Root Causes

Case-fatality in a filovirus outbreak rises when the interval between symptom onset and clinical care lengthens, because supportive treatment, fluids, electrolyte correction and organ support, is time-sensitive; a patient reaching a saturated treatment site late in the disease course has a materially worse prognosis than one admitted early, independent of the virus itself.

Treatment-site saturation compounds this: the same bed-capacity imbalance straining Nord-Kivu and the same testing bottleneck consuming isolation beds nationally both push presentation and admission later in the disease course, which is why Africa CDC links the case-fatality rise to logistics rather than pathogen change.

What could happen next?
  • Meaning

    The rise from 39.7% to 44.1% case-fatality is attributed by Africa CDC to system strain, later presentation and saturated sites, not to a change in Bundibugyo ebolavirus's underlying lethality.

  • Consequence

    A rising case-fatality rate driven by system strain will likely track the same bed-misallocation and testing-delay problems documented elsewhere in this update, rather than resolve independently.

First Reported In

Update #12 · Two-thirds of Ebola deaths never reach a ward

Africa CDC· 31 Jul 2026
Read original
Causes and effects
This Event
Ebola case fatality crosses 40% in DRC
A threshold has been crossed, and the reason given is the state of the response rather than any change in the virus.
Different Perspectives
UK Health Security Agency
UK Health Security Agency
UKHSA said egg consumption remains the strongest signal in its 207-case Salmonella Enteritidis investigation. The genomic cluster and 38% hospitalisation among people with available information make exposure identification a public-health priority.
GLEWS+
GLEWS+
GLEWS+ assessed spillover risk from clade B MERS in Nile Basin camels as high if the clade establishes, while rating evidence for spread in camel populations low confidence. The joint assessment makes whole-genome sequencing the next test of the threat.
WHO Regional Office for Africa
WHO Regional Office for Africa
WHO's Africa office said transmission in DR Congo is outpacing control efforts after laboratory capacity reached 19 sites and treatment capacity exceeded 1,300 beds. The assessment puts access, insecurity, community deaths and late care-seeking ahead of a simple equipment shortage.
People in Guatemala
People in Guatemala
Guatemala's population now carries the region's largest reported measles burden, with 30,371 confirmed cases and 26 deaths. The scale shifts practical attention from the Mexico-centred frame that followed the World Cup's travel consequences.
Pan American Health Organization
Pan American Health Organization
PAHO rated regional measles risk very high after recording 47,459 confirmed cases and 44 deaths through week 28. It names vaccination coverage, accumulated susceptibles and mass gatherings with broad international participation as general risk factors.
Chinese health authorities
Chinese health authorities
China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.